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Milk-lipid droplets are secreted from mammary epithelial cells with an outer 
envelope of membrane, called the milk lipid globule membrane, which consists of a 
phospholipid bilayer and protein coat. Constituents of this protein coat, including 
butyrophilin 1a1 (Btn1a1) and xanthine dehydrogenase/ oxidase (Xdh/Xo), are 
presumed to function in milk-lipid secretion. We postulate that Btn1a1 is targeted to 
the apical membrane and binds to Xdh/Xo, which is present on the surface of 
intracellular lipid droplets. To determine the distribution of Btn1a1 and Xdh/Xo in 
lactating mammary tissue, we introduced recombinant adenoviral vectors encoding 
Btn1a1 or Xdh/Xo fused to variants of green fluorescent protein (GFP) into mouse 
mammary gland. The distribution of the respective expressed fusion proteins was 
determined by confocal microscopy. Results showed that Btn1a1 and Xdh/Xo were 
targeted to the apical plasma membrane and the surface of intracellular lipid droplets, 
respectively. Study of the distribution of either fusion proteins in the secreted droplets 
showed that the membrane forms crescent-like and blebbing structures, thus 
confirming earlier electron microscopic data, which suggested that the milk-lipid 
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Mammals are distinguished from other vertebrates because they have 
mammary glands, which are skin glands that secrete milk solely for the sustenance of 
their young. Lactation is the crucial time for the post-partum survival of neonates (1) 
and in the first several weeks to months of their life, milk is their only source of 
nutrients and water. Major milk components include water, ions, proteins, lactose, fat, 
and immunoglobulins. The composition of milk may vary because of species, diet, 
breed, genetics, mastitis, stage of lactation, as well as environmental conditions and 
many other factors. For example, seals have a comparatively high amount of fat and 
low quantities of water in their milks, which allows the mother to provide large 
amounts of energy for her young with a minimal expenditure of water, so that the 
young keep body temperature and grow rapidly in cold climates.  
Raw whole milk can be separated into skim milk and cream by low-speed 
centrifugation. Generally the milk is first defatted (the cream is removed) at low 
centrifugal forces (about 5,000 to 10,000 x gav, for 10 min), to prepare skim milk, 
which contains soluble proteins, casein micelles, ions, carbohydrates and water. If the 
skim milk is centrifuged at higher g forces, the casein, which is in the form of 
micelles, sediments as a white pellet, leaving a soluble fraction, which is called whey. 
The whey fraction contains soluble proteins, carbohydrate, water and minerals. 
Major development of the mammary gland occurs during gestation and 
differentiation of the alveolar epithelium leads to the copious secretion of milk at the 
onset of parturition. The mammary gland is one of few tissues that can repeatedly 
undergo growth, functional differentiation, and involution during adult life. 
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Mammary gland development is initiated in the early fetal stage, continues around the 
time of puberty, and develops to a peak during late pregnancy. A single-layered sheet 
of cells derived from ectoderm forms a mammary band, which gives rise to the 
mammary buds at early stages of embryological development, followed by a dense 
mesenchyme. In the mouse, stromal cells develop from the mesenchyme and become 
a fat pad, which consists mostly of adipocytes, fibroblasts, nerves, and blood vessels. 
The streak canal, teat, and gland cisterns begin to form from the mammary bud. 
Essentially at birth the gland consists of a limited duct system penetrating into 
adipose and connective tissue. Most mammary development takes place during 
gestation, and the greatest promoters of mammary growth are the hormones of 
pregnancy. Depending upon species, major hormones include estrogen, which is 
required for ductal development, progesterone, which is required for alveolar 
morphogenesis, and prolactin, which is required for lactogenesis. During this time, 
extensive arborization of the ductal system and formation of lobulo-alveolar 
structures take place and the mammary gland is eventually filled with alveoli. 
Mammary epithelial cells are fully differentiated at parturition and become polarized 
with a basolateral region, a Golgi complex, and apical cytoplasm filled with secretory 
vesicles and lipid droplets (2). 
Two major cell-types are responsible for the production and removal of milk 
from the gland: secretory epithelial cells and myoepithelial cells. The former line the 
alveolar luminae and secrete all of the major components of milk. The later are 
located beneath the secretory epithelium and function in milk-ejection. The milk 
ejection reflex involves the oxytocin-induced contraction of the myoepithelial cells to 
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increase internal pressure within the alveolus and force stored secretions into the 
ducts and subsequently to the nipple.  
Mammary growth continues during the early days of lactation in many 
species. In mouse, there is a transient surge in mammary cell proliferation 2 to 3 days 
postpartum. This is consistent with the results in this thesis, in which we detected the 
highest levels of expressed recombinant protein during early lactation. However, 
increased growth after parturition is prevented if suckling is not permitted in most 
species and the gland undergoes premature involution. 
The mammary gland reverts to a virgin status morphologically when the 
neonates are weaned unless there is the stimulation of another pregnancy. The 
secretory epithelial cells undergo apoptosis, and the gland alveolar structure is 
eventually degraded (3). Involution can be stimulated at any stage of lactation by 
removal of the suckling neonates. Further cycles of mammary gland proliferation and 
differentiation occur at the onset of succeeding pregnancies (2).  
Although the proportion of each constituent differs among species, due to the 
different needs of the neonate and nature of the environment, the qualitative 
composition of milk is very similar among mammals. Lipid droplets, caseins, lactose 
and water are major constituents in nearly all species. Lactose is the major 
carbohydrate in most milks (4). Besides providing digestible carbohydrate, it also 
plays a major role in controlling the osmotic balance between milk and mammary 
secretory epithelial cells by drawing water into milk across the secretory vesicle 
membranes and the apical surface (5). All milks contain protein, which as discussed 
above, can be separated by centrifugation into casein and whey fractions.  
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Caseins compromise up to 80% of total milk protein in cows (6) and are in the 
form of micelles. The α-casein and β-caseins are calcium-binding proteins, which 
form the core of the micelle, with κ-casein surrounding the outer surface. Milk fat is 
also a component conserved in all milks. The major lipids in milk are triacylglycerols, 
which are secreted as fat globules covered with a protein coat and a bilayer membrane 
of phospholipids and integral and peripheral proteins. The protein coat and the bilayer 
membrane are collectively called the milk-lipid-globule- membrane (MLGM) (7). 
The potential role that major protein constituents of the MLGM may play in the 
secretion of milk-lipid droplets is the subject of this thesis. 
Both the integral and peripheral proteins of the MLGM may play important 
roles in coating and stabilizing newly synthesized fat droplets and milk-lipid droplets. 
Major proteins of the membrane include the redox enzyme xanthine 
dehydrogenase/oxidase (Xdh/Xo), butyrophilin 1a1 (Btn 1a1), mucin 1 (MUC1), 
mucin 15B, lactadherin, CD36, adipocyte differentiation-related-protein (ADRP) or 
adipophilin (ADPH) (reviewed in (8)). Two major MLGM proteins, the membrane 
protein butyrophilin 1a1 (Btn 1a1) and the soluble protein xanthine dehydrogenase / 
oxidase (Xdh/Xo) have been proposed to play a functional role in milk-lipid secretion 
and they are the major focus of this thesis research (9).  
Triacylglycerols are the principal components of cream in milks and comprise 
up to 97% of the total lipids in cows’ milk (10, 11). Lipids are also present in the 
skim milk as membrane fragments (12). In origin, lipid is first formed as small 
droplets on the membranes of the rER (10, 11, 13, 14), although the exact location of 
lipid synthesis is still unknown. Possible locations could be the cytoplasmic surface, 
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luminal surface or between the bilayer membrane (6, 9, 13). In one point of view, 
lipid molecules nucleate during synthesis on the cytoplasmic surface to form small 
droplets, which are directly released into the cytoplasm (14). Some membrane 
proteins, such as Btn1a1, are presumed to be excluded from the covering of the 
microlipid droplets, whereas other proteins, including ADPH and lipids such as 
glycerophospholipids become incorporated into the surface coat of the droplets (15, 
16). 
Following release into the cytoplasm, the newly synthesized lipid droplets, 
which at this stage are called microlipid droplets (MLDs) (17) migrate toward the 
apical plasma membrane by unknown mechanisms. Elements of the cytoskeleton 
including microtubules and actin may play major roles (18). Some of the MLDs, 
which are small in size (diameters less than 0.5 μm), fuse together and form bigger 
droplets during transport to the apical pole of the cell. The fused and enlarged lipid 
droplets are called cytoplasmic lipid droplets (CLDs). CLDs are considered to be the 
direct precursors of large milk-lipid droplets, while MLDs are assumed to give rise to 
the small lipid globules in milk (15). Separation of MLDs and CLDs shows that they 
have similar coat compositions, which presumably reflects their common origin in the 
rER (15, 19).  
Fat droplets are secreted into the alveolar lumen after targeting to the apical 
membrane of mammary epithelial cells. Three pathways have been proposed. MLDs, 
which do not fuse with other MLDs or CLDs and do not enlarge in size, migrate to 
the apical pole and are gradually coated with plasma membrane and secreted from the 




Figure 1. Three major pathways of lipid droplet transit and secretion from 
mammary epithelial cells 
 
MLDs are synthesized in the rER and move to the apical surface. I: MLDs fuse with 
each other and form larger CLDs as they are transported to the apical surface, where 
they are secreted as CLDs (B). II: The MLDs are transported to the apical surface 
without changing their size and are secreted as MLDs (A).  III: The CLDs are 
surrounded by secretory vesicles, which form intracytoplasmic vacuoles around the 
fat droplets in the cytoplasm. After fusing with the apical PM the fat droplet is 
exocytosed from the cell (C). D shows a combination of secretory mechanisms B and 
C.  Casein and other milk components are secreted by exocytosis from secretory 
vesicles at the apical PM (E). Apical plasma membrane (APM); basal plasma 
membrane (BPM); cytoplasmic crescent (CR); rough endoplasmic reticulum (RER); 
lipid droplet (LD); Golgi apparatus (GA); cytoplasmic lipid droplet (CLD); 
microlipid droplet (MLD); nucleus (N); secretory vesicle (SV). Figure and legend 




In an alternative pathway the CLDs enlarge dramatically in the apical pole of the cell 
by continued fusion with smaller droplets and are surrounded with apical plasma 
membrane until a narrow neck is formed. After the neck fuses together and seals, the 
droplets are released into the lumen. The enlarged CLDs comprise the large droplets 
in milk (20). In this mechanism some of the droplets acquire cytoplasmic inclusions, 
which have a crescent-like appearance in electron micrographs of secreted milk-lipid 
droplets. Such cytoplasmic inclusions are much more common in some species, e.g., 
rabbit and human, than others, e.g., cow and guinea pig (21). In a very different view, 
the lipid droplets are presumed to associate with secretory vesicles from the Golgi 
apparatus in the apical pole of the cell (22, 23). The secretory vesicles either partially 
or completely surround the droplets and the membranes of the vesicles fuse together 
to form a cytoplasmic vacuole. The contents of such vesicles are then released from 
the apical surface by exocytosis (Figure 1). A combination of both mechanisms has 
also been proposed (Figure 2). 
The actual mechanism of milk-lipid droplet secretion at the molecular level 
has not yet been established. It is not clear how the droplets fuse, how lipid droplets 
are transported to the apical membrane, what forces are involved in the targeting, and 
how the droplets acquire the outer coat of membrane during secretion. Several 
mechanisms of milk-lipid secretion have been proposed (9). Our aim is to test the 
most accepted model:-that milk-lipid droplets bind to the apical membrane through 
interactions between membrane- and lipid-droplet- associated proteins, and that these 
proteins are secreted with the lipid in the MLGM (9, 16).  






Figure 2. The two major proposed mechanisms of milk-lipid droplet secretion 
), 1, apical plasma membrane surrounds the fat droplet. 2, a neck forms. 3, neck 
from the apical membrane of mammary epithelial cells  
 
(a
narrows and finally fuses. (b), 1, secretory vesicles from the Golgi apparatus surround 
fat droplets together with the apical plasma membrane; 2, membranes of the secretory 
vesicles fuse with each other and with the plasma membrane; 3, after secretory 
vesicle and plasma membrane fusion, the fat droplets are secreted. Figure and legend 
reproduced from (6) with permission. 
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membrane, the droplet remains a constant distance of about 10-20 nm from the outer 
membrane bilayer (22) (Figure 3a). This layer consists of protein, and appears as a 
fuzzy electron dense coat in electron micrographs of isolated membrane (24) (Figure 
3c). Freeze-etch electron microscopy has shown that areas of the protein coat appear 
as a very ordered paracrystalline structure with hexagonal symmetry in freeze-etched 
preparations (25) (Figure 3b). 
Immediately after milk secretion, the bilayer membrane uniformly covers the 
milk-lipid droplet surface (22). However in fixed specimens the structure of the 
MLGM alters in the luminae of alveoli and ducts, and the membrane appears to be 
structurally rearranged ( Figure 423, 24, 26) ( ). The inner surface of the membrane 
bilayer of the MLGM and the outer surface of the lipid droplet tend to fuse, forming 
areas of apolar contact. Expansion of the contact zones between the two surfaces 
leads to the formation of intervening areas, in which the protein coat is condensed 
(22) and the outer membrane bilayer blebs off in the form of vesicles carrying the 
amorphous coat derived from the surface of the droplet (12, 24). The extent that this 
vesiculation process occurs in vivo has been questioned because of the difficulty of 
chemically fixing membrane-coated lipid droplets for electron microscopy (9).  Data 
obtained during this current research project directly addresses this issue. 
The mechanism of MLGM formation has attracted much interest. Mather and 
Keenan have suggested that MLGM proteins play an important role in lipid-droplet 








Figure 3. Electron microscopy of lipid secretion and MLGM formation 
 
a, Lipid droplet budding out from the apical surface of secretory cell (Mather, I. H., 
unpublished observations) b, Freeze-etch microscopy of inner surface of MLGM 
showing protein coat with hexagonal symmetry (25). c, Electron micrograph of 




Figure 4. Model of reconfiguration of MLGM and fat globule interactions after 
secretion 
 
The inner surface of the bilayer membrane and outer surface of the lipid droplets may 
interact with each other after secretion. Crescents, caps, and blebs may form. a, 




In this hypothesis it is proposed that proteins on the surface of the intracellular 
lipid droplet and proteins in the apical plasma membrane interact and bind to each 
other as an initial step in the formation of the MLGM. Potential interacting partners 
include Btn1a1, microtubules, Xdh/Xo and ADPH. An analysis of the topology of the 
MLGM from washed fat globules (29) and other considerations (9) suggest that 
Btn1a1 and Xdh/Xo may play a major role in formation of the MLGM and these 
proteins are discussed separately below. 
Butyrophilin (Btn1a1) is the only major protein of the MLGM with a 
cytoplasmic tail long enough to bind with other proteins (Figure 5). Btn1a1 is also 
one of the most abundant proteins in the MLGM in many species including human 
and cow (30, 31) and it is specifically expressed in lactating mammary gland (32), 
especially during lactation, and also immediately preceding the onset and following 
the cessation of lactation. Most importantly, knock-out of the butyrophilin gene in 
mice causes disruption of MLGM structure and regulated milk-lipid secretion (33) 
(Figure 6), providing direct evidence that Btn1a1 functions at same stage in milk-
lipid secretion. 
Btn1a1 forms one of a subfamily of ten genes in the immunoglobulin (Ig) 
superfamily, identified in human, mouse and other species (35-37). The structure of 
most Btns comprises two Ig-folds in the exoplasmic domain, a single membrane 
anchor, and a B30.2 domain, which is the predominant part of the cytoplasmic 
domain (38). A recent X-ray crystal structure study shows that this domain has 
multiple β strands, and comprises a β sandwich and is similarly present in many other 







Figure 5. Predicted topology of major proteins in MLGM 
 
Integral proteins include MUC1, CD36 and BTN. MUC1 and BTN are type 1 
membrane proteins with the N-termini on the exoplasmic side and C-termini on the 
cytoplasmic side. BTN is a member of the immunoglobulin superfamily with two 
immunoglobulin-like domains (IgI, IgC1) and a single cytoplasmic tail. XO (xanthine 
oxidase) and ADRP (adipophilin) are peripheral membrane proteins that do not have 
membrane anchors. These two proteins are probably associated with the cytoplasmic 











+/+Figure 6. Electron micrographs of lactating mammary tissue from Btn , Btn +/-
-/-, and Btn  mice 
 
(a-c) secretory epithelial cells; (e-f) MLGM on lipid droplets in milk. (a), (d) 
micrographs of tissue and lipid droplets of wild type mice; (b), (c), (e), (f): 
micrographs of tissue and lipid droplets of knock-out mice; (b), (c): lipid droplets are 
not synthesized and secreted normally in knock-out mice compared to wild type; (e), 
(f): MLGM is discontinuous and disrupted in knock out mice (33). (a-c) bars 5μm, (d-
e) bars 1μm. 
 14
 
Xanthine dehydrogenase/oxidase (Xdh/Xo or Xdh) may be linked to milk-
lipid secretory activities because it binds to Btn1a1 (41). Xdh/Xo is one of the most 
abundant proteins in the MLGM in many species and is highly expressed, as a soluble 
protein, in lactating mammary tissue (42, 43). 
Xdh/Xo is a redox enzyme that is widely distributed in many tissues in 
mammals and functions in purine metabolism. Xdh/Xo is a homodimer with an 
aggregate molecular weight of 300,000 Da. Each monomer has four domains, two 
Fe /S2 2 domains at the N-terminus, a central flavin binding domain, and a C-terminal 
molybdopterin binding domain (44). Two forms of Xdh/Xo are present in mammals: 
an oxidase and a dehydrogenase. The dehydrogenase preferentially utilizes NAD+ as 
electron acceptor, which is converted to NADH+/H+. The oxidase form transfers 
electrons from the reduced enzyme to molecular oxygen, which is converted to 
hydrogen peroxide and superoxide radicals. Purines bind to the enzyme at the 
molybdopterin site, and NAD+/oxygen interacts with the FAD+ domain. Xdh/Xo can 
be converted into the oxidase form by oxidation of key sulfhydryl residues (45).  
Structurally, Xdh/Xo is a butterfly shaped dimer (46). Because the distance between 
the two monomers is not close enough for electron transfer to occur, each of the 
monomers is catalytically independent. In the mammary gland, Xdh/Xo expression is 
significantly increased during pregnancy and becomes maximal around mid-lactation, 
which suggests an important role in milk synthesis or secretion (47). Furthermore, 
lactating mammary glands have higher levels of Xdh/Xo compared to most other 
mammalian tissues (48). Thus, although the reported main function of Xdh/Xo is in 
the oxidation of purines, in the mammary gland Xdh/Xo may have other funcions 
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related to lactation. Xdh/Xo has been detected in both the cytoplasm and the apical 
surface of mammary epithelial cells during lactation (49). Most significantly, the 
Xdh/Xo+/- heterozygote has a very similar lactation phenotype to that of the Btn-/- 
mouse; secretion is disrupted and lipid droplets accumulate in the cytoplasm (Figure 
7). Milk contains fewer fat droplets in the Xdh/Xo+/- mice, than milk from wild-type 
mice (47). These results provide direct evidence that the normal expression of 
Xdh/Xo is required for regulated lipid secretion. [Note: The lactation phenotype of 
the homozygous knock-out Xdh/Xo mouse (Xdh/Xo -/-) cannot be analyzed because 
the mice do not live beyond 6 weeks of age]. 
Although these above results imply that Btn1a1 and Xdh/Xo may function in 
milk-lipid secretion, many major questions still remain unanswered in the field. These 
questions include: what is the distribution of Btn1a1 and Xdh/Xo in mammary 
secretory epithelial cells, what is the targeting mechanism of milk-lipid droplets to the 
apical membrane, and is interaction between Btn1a1 and Xdh/Xo essential for lipid 
secretion? Based on the available data we propose the following working hypothesis: 
Btn1a1 is synthesized and processed through the secretory pathway and located on 
the apical membrane while Xdh/Xo is synthesized in the cytoplasm and distributed to 
the surface of intracellular lipid droplets, during their transport to the apical pole of 
the cell. Btn1a1 self-associates in the plane of the apical membrane and binds to 
Xdh/Xo thus bringing the lipid droplets in contact with the membrane bilayer and 
initiating formation of the MLGM. Further interactions between Btn1a1 and Xdh/Xo 




+/- +/- +/- +/+ 





Figure 7. Mammary tissue from heterozygous mice deficient in Xdh/Xo.  
 
+/-Histological analysis of resin-embedded mammary glands of wild-type and Xdh  
mice. The arrows indicate epithelial cells in which accumulated fat droplets appear to 
break out from the apical outface of the cell. (a-b) light micrographs; (c-e) electron 
micrographs show disruption of lipid droplets, similar to that caused by a deficiency 









Figure 8. Postulated hypothesis for the secretion of lipid droplets from 
mammary epithelial cells 
 
(a) Btn1a1 self-associates in the form of tetrameric/ pentameric complexes in the 
apical plasma membrane. (b) Xdh is synthesized in the cytoplasm, binds to the 
surface of milk-lipid droplets, and is transported together with the lipid droplets to the 
apical pole of the cell. (c) Xdh on the surface of the lipid droplets binds with 
multimeric forms of Btn1a1, bringing the lipid droplets to the apical membrane 
bilayer and initiates formation of the MLGM. (d) Further interactions between Btn1a1 
and Xdh lead to expulsion of the lipid droplets from the cell.  
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Recent advances in the in vivo expression of recombinant protein allow us to 
test several aspects of this hypothesis. The mammary gland provides a good model 
for in vivo study, because the gland parenchyma is directly accessible through the 
mammary duct in the nipple, thus allowing the introduction of vectors encoding target 
genes to express recombinant proteins of interest. Investigators have taken advantage 
of such intraductal injection techniques to study the permeability of the mammary 
epithelium to ions and sucrose in goats and mice (51), and DEAE-dextran-mediated 
transfection was used to express reporter proteins including human growth hormone 
in the guinea pig mammary gland (52). More recently, adenoviral vectors encoding a 
green fluorescent protein (GFP) reporter were injected intraductally into the mouse 
mammary gland to evaluate transduction efficiency (53). 
In this thesis research, we used adenoviral vectors to explore our questions 
about milk-lipid secretion in mammary epithelium cells. Adenoviral vectors were 
constructed encoding fusion proteins of either wild type Btn1a1 or Xdh/Xo with a 
fluorescence tag comprising enhanced yellow fluorescent protein (EYFP). The 
expressed recombinant forms of Btn1a1 and Xdh/Xo were fused with the 
fluorescence tag at the respective C-termini. We discuss the transduction of the 
mouse mammary gland with adenoviral vectors encoding these constructs. Optimal 
conditions for infusion of the vectors and expression of the proteins were tested. The 
steady-state distributions of the Btn1a1 and Xdh/Xo fusion proteins were determined 
by microcopy of fixed tissue and freshly collected milk samples. 
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Materials and Methods: 
Materials: 
RPMI 1640, trypsin-EDTA and penicillin streptomycin fungizone (PSF) were 
from Gibco (Gaithersburg, MD). Fetal calf serum was from Atlanta Biologics 
(Atlanta, GA). Mowiol was from CalBiochem (La Jolla, CA). Tris, sodium dodecyl 
sulphate (SDS), ammonium persulphate, N,N,N’,N’ tetramethylethylenediamine 
(TEMED), goat anti-(rabbit-IgG) conjugated to horse-radish peroxidase, gelatin, 
nitrocellulose, ampholines, bromophenol blue, Coomassie brilliant blue R-250, 
acrylamide, N,N’ methylenebisacrylamide, and Triton X-100 were obtained from 
Bio-Rad Laboratories (New York, NY). Bicinchoninic acid (BCA) and bovine serum 
albumin (BSA) were from Pierce Chemical Company (Rockford, IL). ECL™ 
Western blotting detection reagents and Hyperfilm™ were obtained from Amersham 
Life Sciences (Buckinghamshire, England). Rabbit anti-GFP IgG was from Molecular 
Probes (Eugene, Oregon). Mouse mammary gland infusion micropipettes were 
obtained from Drummond Scientific (Broomall, PA). O.C.T. Compound was from 
Tissue-Tek (Torrance, CA). All other chemicals and reagents were from Fisher 
(Pittsburg, PA). 
Adenoviral vectors were constructed in the laboratory of Dr. Jerry Schaack 




Storage of vectors 
For long-term storage, stocks of each adenoviral vector were kept in storage 
buffer (10 mM Tris-HCl, pH 7.5, 10 mM histidine, 75 mM NaCl, 1 mM MgCl2, 100 
μM EDTA, 0.5% v/v EtOH, 50% v/v glycerol) at -80oC. Working stocks of each 
vector were diluted to 2.7x1010 pfu/ µl in the same buffer and stored at -20oC for a 
maximum of one month. Immediately before the infusion of adenoviral vectors into 
mouse mammary glands, vectors were diluted to 2.7x107 pfu/ µl in Krebs Ringer’s 
buffer (138 mM NaCl, 8.1 mM Na HPO , 1.2 mM K HPO , 2.7 mM KH PO2 4 2 4 2 4, 0.9 
mM CaCl , 0.5 mM MgCl ) and kept on ice before use. 2 2
 
Cell culture and transduction with adenoviral vectors 
HEK293 cells were grown on plastic tissue culture plates in RPMI 1640 
medium containing 10% FBS and 1% penicillin/streptomycin/l-glutamate at 37oC in 
an atmosphere of 95% air and 5% CO2. HEK293 cells were grown to 60-80% 
confluency and were counted using a hemacytometer (Bright-Live, Buffalo, NY). 
Cells were transduced with adenoviral vectors by adding the diluted vectors from the 
working stocks (2.7 x 107 pfu/ μl) to the culture medium based on the amount of cells 
in each tissue culture plate, to ensure that fixed vector/cell ratios were applied. Vector 
titers ranging from 0.1 to 25 pfu/ cell were tested. Transduced cells were incubated 




 Lysis and harvest of transduced HEK293 cells  
Cells were washed three times with 3 ml of ice-cold Dulbeco's phosphate-
buffered saline (D-PBS: CaCl - and MgCl2 2- free, Sigma), scraped from the culture 
plate in 800 μl of D-PBS, and transferred to 1.5 ml eppendorf centrifuge tubes. The 
harvested cells were then centrifuged at 1,000 gav for 30 sec, the D-PBS was removed 
and the cells were resuspended in 250 μl lysis buffer (20 mM HEPES, pH 7.4, 150 
mM NaCl). Cells were lysed by three consecutive rounds of freeze-thawing, firstly at 
-80oC and then on ice, and the lysates were then centrifuged at 15,000 gav for 30 min 
at 4°C. The lysate supernatants were collected and transferred to fresh 
microcentrifuge tubes, the pellets were resuspended with the same volume of lysate 
buffer and both fractions were stored at –20oC. 
 
 Transduction of mouse mammary glands in vivo 
Mice were anesthetized by the intraperitoneal injection of avertin at a dosage 
of 125 to 250 mg/ kg body weight and kept warm under the light of a microscope 
illuminator (Fisher). Glands were washed with 70% ethanol, and the hair was 
trimmed around the nipple to be infused. Glass micropipettes for infusion were 
prepared by pulling the glass tip over a Bunsen flame into a fine tip of 60 to 75 μm 
and the ends fire-polished to remove sharp edges.  
A stock of adenoviral vector (2.7 x 107 pfu/ μl) was made by diluting the 
original adenoviral vector stock with storage buffer as above. Final doses (2.7 x 107 
pfu for number 4 mammary glands; 2 x 106 pfu for number 3 mammary glands, as 
described by Russell. et al, ( 753) were made by diluting the 2.7 x 10  pfu/ μl stock 
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with 100 μl of sterile filtered Ringer's solution. This dilution was made immediately 
before the infusion to ensure the stability of the vectors. The solution was loaded into 
a 25 µl Wiretrol II disposable glass micropipette with a stainless steel plunger (no. 5-
000-2050; Drummond Scientific Company, Broomall, PA). By using a 
micromanipulator (World Precision), the tip was gently inserted into the teat canal, 
and the solution was slowly injected into the luminal spaces of either the number 3 or 
number 4 mammary glands. Micropipettes were washed three times each with 
Ringer’s solution, 70% ethanol and distilled water between each vector infusion. 
Each gland was infused four times with 25 µl aliquots of vector, for a total of 100 µl 
per gland. 
 
 Collection of milk 
Mice were separated from their litters for approximately 3 h and were then 
injected i.p. with avertin (125 to 250 mg/ kg body weight) and 0.2 I.U. of oxytocin in 
physiological saline. Milk was collected with a hand-held vacuum device into 
capillary tubes as described by Teter, et. al (54). The milk was centrifuged for 15 min 
at 15,000 gav at room temperature in a hematocrit centrifuge and the fat and skim milk 
samples, partially cleared of casein, were collected by breaking the capillary tubes at 
the skim-milk/lipid interface. Milk was also spotted onto microscope slides after 
dilution with PBS and sealed under cover slips with nail polish to examine the fat 




 Collection of mouse mammary tissues 
Mice at either the 3rd day or the 20th day of lactation were asphyxiated by 
immersion in CO2. Mammary glands were rapidly excised, weighed, spread on a 
glass plate on top of ice to keep cold, and homogenized in 10 mM Tris- HCl, pH 7.2, 
140 mM NaCl containing protease inhibitors (20 mM HEPES pH7.0 containing 150 
mM NaCl, TPCK 0.125 mM, TLCK 0.125 mM, PMSF 1 mM, EACA 10 mM, and 
aprotinin 0.2 units). The tissue was minced finely and homogenized in a Dounce 
homogenizer in the above homogenization buffer containing protease inhibitors as 
described above. The homogenized tissue was then centrifuged at 15,000 gav for 10 
min at 4o C. Pellets were resuspended with 200 μl of PBS. 
 
 Protein determination 
Protein was determined by the BCA™ protein assay (Pierce) according to the 
manufacturer’s instructions, using bovine serum albumin as a standard (55). 
 
 SDS/ Polyacrylamide gel electrophoresis and Western blot 
SDS-PAGE was performed in 8% (w/v) acrylamide gels as described by 
Laemmli et. al.(56). Protein samples from cell lysates or homogenized tissue were 
prepared by heating at 95o C for 3 min in SDS-PAGE Laemmli buffer. Samples (10-
20 μg protein) were separated for 3-4 h at a constant current of 30 mA/slab gel and 
then transferred to nitrocellulose membrane using the method of Towbin et. al. (57). 
Membranes were blocked with 5% dry milk/high-salt TBS (0.5M NaCl, 20 mM Tris-
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HCL, pH 7.4) overnight and then incubated with diluted primary anti-GFP antibody 
for 1 h in 2.5% dried milk/Bio-Rad TBS. Anti-peptide rabbit polyclonal antibodies to 
the C-terminal amino acid residues of Btn1a1 were prepared as described by Ogg. et 
al. (33) and purified as described by Banghart et al. (29). The membranes were 
washed three times, firstly for 15 min, and then twice for 10 min each time, with 
high-salt TBS and then incubated with goat-anti-rabbit IgG conjugated to horseradish 
peroxidase (Bio-Rad blotting grade) for 1 h in 2.5% dried milk/high-salt TBS. The 
membranes were then washed again three times as described above. 
Chemiluminescence was used to detect immunoreactive protein, using the ECL kit 
from Amersham according to the manufacturer’s directions. 
 
 Histology 
Mouse mammary glands were spread out onto microscope slides in Petri 
dishes, and covered with 4% (w/v) paraformaldehyde in PBS buffer, pH 7.25 and 
fixed overnight at 4oC. The whole gland was dissected into three major parts denoted 
as the nipple area and the medial and distal areas. Each of the fixed parts was 
chopped into 1mm pieces, which were placed in molds containing O.C.T. compound 
and then quick-frozen by holding them in liquid nitrogen. The embedded tissue was 
sectioned at a thickness of 6-8 μm using a Leica Frigocut 2800E cryomicrotome. The 
sectioned tissue was washed with PBS on microscope slides to remove O.C.T. 
compound and then mounted in Mowiol, protected with a coverslip, and examined 





Based on the potential roles of Btn1a1 and Xdh/Xo in milk-lipid secretion, we 
focused on two research aims for this thesis research. Firstly, we tested the feasibility 
of expressing Btn1a1 or Xdh/Xo as fusion proteins with variants of GFP in HEK 293 
cells using adenoviral vectors. Secondly, to study the distribution of Btn1a1 and 
Xdh/Xo in mammary epithelial cells and milk, we infused the adenoviral vectors into 
mouse mammary glands through the streak canal of the nipple and examined the 
distribution of the expressed proteins in tissue and milk by confocal microscopy.  
As a first step towards constructing adenoviral vectors, recombinant plasmids 
encoding either Btn1a1 or Xdh/Xo fused with EYFP or ECFP respectively at the C-
termini were made by Dr. I. Mather. The recombinant plasmids were based on the 
pEYFP-N1 plasmid from Clonetech with mutations incorporated into the EYFP 
cDNA to prevent self-association of the expressed fluorophores (58). The respective 
cDNAs encoding each entire fusion protein were excised from the completed 
Clonetech plasmids and used by Dr. J. Schaack to prepare adenoviral vectors (59). 
Plasmid and adenoviral vector construction is summarized in Figure 9. The plasmids 
were defined as pBTN-EYFP and pXDH-EYFP to indicate EYFP is fused to the C-
terminus of Btn1a1 or Xdh/Xo in the fusion protein. The adenoviral vectors were 
defined as Adv-BTN-EYFP and Adv-Xdh-EYFP, respectively. 
To test whether fusion proteins of Btn1a1 or Xdh/Xo with EYFP were 
expressed as full-length proteins, the respective plasmids were transfected into 
















Figure 9. Construction of Expression Plasmids and Adenoviral Vectors 
 
(a), Restriction map and multiple cloning site of pEYFP-N1 from Clonetech. Unique 
restriction sites are in bold. The Xba I site (*) is methylated in the DNA provided by 
Clontech. (b), Schematics of cDNAs encoding the respective fusion proteins inserted 
into pEYFP-N1. The cDNAs encoding either Btn1a1 or Xdh/ Xo were fused at the 3’-
end to the 5’ end of the cDNA for EYFP in the plasmid and then recovered by 
digestion with Nhe1 and Not1. (c), Adenoviral vector construction. cDNAs containing 
Btn1a1 or Xdh/ Xo cDNAs fused with EYFP were cloned into the pShuttle-CMV 
vector downstream of a CMV promoter. The construct was then cleaved with 
restriction endo-nulease to linearize it and transformed together with adenoviral 




fusion proteins of the expected size and cellular locations (Figure 10). Xdh/Xo, 
which is a soluble protein, remained in the supernatant when cell lysates were 
centrifuged. The molecular weight for Xdh/Xo monomer is 150 kDa and EYFP is 27 
kDa. Therefore the theoretical molecular weight for fusion protein Xdh-EYFP is 177 
kDa. The protein bands detected by Western Blot have an estimated size of about 170 
kDa, which is very close to the expected size of 177 kDa. Btn1a1 is a membrane 
protein; it stays in the post-nuclear pellet after centrifugation of the cell lysates. The 
molecular weight of Btn1a1 is 67 kDa. Therefore the expected size for fusion protein 
Btn1a1-EYFP was determined to be 96 kDa by Western blot. The double bands of 
Btn1a1 (Figure 10, lanes 2, 3) are glycosylated variants, confirmed by digesting with 
N-glycanase to remove the N-linked glycan (Mather, I.H. unpublished observations). 
After we had confirmed that the Btn1a1 and Xdh/Xo proteins were expressed 
as full-length proteins, the corresponding adenoviral vectors were also tested. 
Adenoviral vectors encoding Adv-BTN-EYFP or Adv-XDH-EYFP were added to 
HEK293 cells at vector /cell ratios ranging from 0.1 to 25 pfu/ cell. For Adv-BTN-
EYFP, cells appeared to be healthy after culture overnight, except for cultures 
transduced with 25 pfu/ cell, which were detached and necrotic. Cells were healthy 
when treated with adenoviral vector titer below 10 pfu/ cell. Fluorescent fusion 
protein was observed in cells transduced with titers between 1-10 pfu/ cell for Adv-
BTN-EYFP and 1 pfu/cell was considered optimal. Similar results were obtained for 
Adv-XDH-EYFP except that cells detached if more than 10 pfu/ cell of vectors were 




Figure 10. Western blot of fusion proteins expressed in HEK293 cells 
 
Lanes 1, untransfected control; 2, Btn1a1-ECFP; 3, Btn1a1-EYFP; 4, Xdh-ECFP; 5, 
Xdh-EYFP; 6, Btn1a1-ECFP and Xdh-EYFP together. 
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below 1 pfu/ cell (Figure 11, 12). 
To test whether fusion proteins of Btn1a1 or Xdh/Xo with EYFP were 
expressed as full-length proteins in cells transduced with the adenoviral vectors, the 
respective adenoviral vectors were added to HEK293 cells at the optimal vector/ cell 
ratios determined above. After overnight incubation, cells were lysed and separated 
into soluble and membrane fractions. Fractions were analyzed by SDS-PAGE and 
Western Blot using anti-GFP antibody (Figure 13). Proteins of the expected sizes, 
namely 170,000 for the fusion proteins of Xdh/Xo and 96,000 for Btn1a1, were 
detected in the post-nuclear supernatant and pellet fractions respectively. More 
protein was detected in cells transduced with higher titers of adenoviral vector.  
Having shown that full-length fusion proteins of Btn1a1 and Xdh/Xo tagged 
with EYFP were expressed in HEK293 cells with the respective adenoviral vectors, 
the cellular distributions of the fusion proteins were determined by fluorescence 
microscopy. As expected, Btn1a1 was targeted to the plasma membrane, whereas 
Xdh/Xo, a soluble protein, was distributed throughout the cytoplasm (Figure 14). 
Btn1a1 was also present in intra-cellular organelles, most probably the rER and Golgi 
complex. 
We next examined the expression of Btn1a1-EYFP and Xdh-EYEP in 
lactating mammary tissue. Lactation in the mouse increases after the second day post-
partum, reaches a peak in the 10th th day, and neonates are typically weaned at the 20  
day of the lactation cycle. Due to development of alveoli in the mammary gland and 








Figure 11. Transduction of HEK293 cells with Adv-BTN-EYFP adenoviral 
vector 
 
Cells were incubated overnight at 37oC, in 5% CO2 95% air, divided equally, and 
grown to 60 to 80% confluency before transduction. Cells were examined after 16 h 
by fluorescence microscopy. Cells in all plates but those treated with 25 pfu/ cell 
grew well. Fluorescence signals were parallel to the transduction titer. (a) 0.1 pfu/ 









Figure 12. Transduction of HEK293 cells with Adv-XDH-EYFP adenoviral 
vector 
 
Experimental conditions were as described in the legend to Figure 11. (a) 0.1 pfu/ 
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Figure 13. Expressed fusion proteins of Xdh/Xo and Btn1a1 with EYFP in 
HEK293 cells, transduced with Adv-XDH-EYFP or Adv-BTN-EYFP 
 
Cells transduced with Adv-BTN-EYFP or Adv-XDH-EYFP, respectively, were lysed 
in lysis buffer, and fractionated by centrifugation at 15,000 gav for 30 min at 4°C. 
Samples (20 µg protein/ lane) were separated by SDS-PAGE and analyzed by 
Western Blot, using anti-GFP antibody. (a) HEK293 cells transduced with Adv-
XDH-EYFP at titers of 0.4, 1, and 10 pfu/ cell, respectively as indicated. The fusion 
protein was mostly detected in the post-nuclear supernatant. (b) HEK293 cells 
transduced with Adv-BTN-EYFP at titers of 0.4, 1, and 10 pfu/ cell, respectively as 














Figure 14. Distribution of fusion proteins Btn-EYFP andXdh-EYFP in HEK293 
cells 
 
Cells were transduced with either 1 pfu/ cell of Adv-BTN-EYFP in (a), or 0.1 pfu/ 
cell of Adv-XDH-EYFP in (b). Experimental conditions were as described in Figure. 
12. Bar 100 µm. Distribution of Xdh-EYFP and Btn-EYFP in HEK293 cells studied 






parturition as possible. To estimate the optimum developmental time for expression 
of fusion proteins, transduced glands were milked at different stages of lactation and 
the presence of fluorescent fusion proteins in the milk-lipid droplets were examined 
by microscopy. 
The fourth mammary glands of C57/BL6 mice were infused with Adv-BTN-
EYFP and Adv-XDH-EYFP adenoviral vectors with 2.7x107 pfu vector/ gland on the 
17th th, 18 , and 19th days of pregnancy and milk was collected on the 3rd th th th, 6 , 12 , 15 , 
and 17th days of lactation. Day 3 of lactation was the earliest practical time that milk 
could be collected. On the 3rd day of lactation about 20 percent of the milk-lipid 
droplets were labeled with fluorescent fusion protein (Figure 15, 16). The ratio of 
fluorescently-labeled lipid droplets decreased to approximately 10 percent on the 6th 
day. After the 6th day, the ratio dropped drastically until the end of lactation, at which 
time there was a minimal amount of protein expression. Mice were killed either on 
the day before or right after weaning (19th, or 20th day of lactation). Fluorescence 
microscopy of the whole mammary gland showed some parts, especially the nipple 
area, were still expressing fusion proteins at this time (data not shown). The same 
experiment was replicated in two other C57/ BL6 mice with similar results (data not 
shown). Mice infused during early lactation did not express fusion protein. Based on 
these results, we conclude that the optimal developmental period for expression of 
fusion proteins is between days 3-6 of lactation, with day 3 (the earliest collecting 
practicable time) being preferable.  
We next used these optimal conditions for the transduction of the mammary 

























Figure 15. Fluorescence microscopy of milk-lipid droplets from mouse 
mammary gland transduced with Adv-XDH-EYFP 
 
C57/BL6 mouse (infused in left fourth gland) was transduced with Adv-XDH-EYFP 
on the 19th day of pregnancy. Milk from the transduced gland was diluted with PBS 
in a volume ratio of 1 to 1, and examined by fluorescence and phase contrast 
microscopy. (a)- (e), fluorescence microscopy. (f)- (j), corresponding phase contrast 
micrographs. (a, f), day 3; (b, g), day 6; (c, h), day 12; (d, i), day 15; (e, j), day 17 of 
lactation. On day 3 and day 6 of lactation, 100 lipid droplets were counted in 3 
randomly chosen areas, an average of 18 lipid droplets on day 3 and an average of 8 

























Figure 16. Fluorescence microscopy of milk-lipid droplets from mouse 
mammary gland transduced with Adv-BTN-EYFP.  
 
C57/BL6 mouse (infused in right fourth gland) was transduced with Adv-BTN-EYFP 
on the 19th day of pregnancy. Milk from the transduced gland was diluted with PBS 
in a volume ratio of 1 to 1, and examined by fluorescence and phase contrast 
microscopy. (a)- (e), fluorescence microscopy. (f)- (j), corresponding phase contrast 
micrographs. (a, f), day 3; (b, g), day 6; (c, h), day 12; (d, i), day 15; (e, j), day 17 of 
lactation. On day 3 and day 6 of lactation, 100 lipid droplets were counted in 3 
randomly chosen areas, an average of 21 lipid droplets on day 3 and an average of 10 





mammary gland and milk. A total of 23 mice were infused with adenoviral vectors 
Adv-BTN-EYFP or Adv-XDH-EYFP at different stages of pregnancy and early 
lactation (Table 1). Protein expression was highest in mice infused in as late a stage 
of pregnancy as possible and analyzed on the 3rd day of lactation. Approximately 30 
percent of the transduced glands were fluorescent on that day. The extent of 
transduction was especially high in the nipple area and some parts of the distal area. 
Glands were transduced with either vector at the same level of efficiency (Figure 17, 
18). 
To test that full-length fusion proteins were expressed in the mouse mammary 
glands, two mice were infused with both adenoviral vectors on the 16th th and 18  day 
of pregnancy and were killed on the 3rd day of lactation. Adv-BTN-EYFP or Adv-
XDH-EYFP (2.7x107 pfu) was infused into the right and left 4th glands, respectively. 
Western blot analysis of the tissue fractions showed that both fusion proteins were 
expressed as full-length proteins (Figure 19; compare with Figure 10, 13).  
To determine the distribution of Btn1a1 and Xdh/Xo in the mammary gland, 
we infused mouse mammary glands with either adenoviral vector in titers of either 
2x107 pfu into the 3rd 7  gland or 6x10 pfu into the 4th gland and examined frozen 
sections (6-8 µm) of tissue or milk samples by fluorescence microscopy. 
For Adv-BTN-EYFP infused tissue, Btn1a1-EYFP was detected the in apical plasma 
membrane (Figure 20). For Adv-XDH-EYFP infused tissue, Xdh-EYFP was seen in 
the cytoplasm and surrounding lipid droplets (Figure 21). Btn-EYFP and Xdh-EYFP 
were also detected in secreted milk-lipid droplets. In both cases, the proteins were 
unevenly distributed around the droplet surface. Discontinuous  
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Figure 17. Expression of Xdh-EYFP in whole mouse mammary gland 
transduced with Adv-XDH-EYFP 
 
A C57/ BL6 mouse was infused with Adv-XDH-EYFP on day 17 of pregnancy and 
sacrificed on day 3 of lactation. The infused and control glands were spread on 
microscope slides and fixed with 4% paraformaldehyde/ PBS at 4oC overnight. (a), 
nipple area; (b), distal area; (c), uninfused control gland. Bar 300 µm. 
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Figure 18. Expression of Btn-EYFP in whole mouse mammary gland transduced 
with Adv-BTN-EYFP 
 
A C57/ BL6 mouse was infused with Adv-BTN-EYFP on day 19 of pregnancy and 
sacrificed on day 3 of lactation. The experimental conditions were as described in 












Figure 19. Expression of Btn-EYFP and Xdh-EYFP in mouse mammary gland 
 C57/BL6 mouse was infused with Adv-BTN-EYFP or Adv-XDH-EYFP on the 16th 
  1            2        3                      4          5         6 
tissue transduced with either Adv-BTN-EYFP or Adv-XDH-EYFP.  
 
A
day of lactation into right or left 4th gland, respectively, and sacrificed on the 3rd day 
of lactation. Milk was collected immediately before the mouse was killed. Mammary 
glands were homogenized in buffer containing protease inhibitors and fractionated 
into soluble and membrane fractions. Samples (20 µg protein/ lane) were separated by 
SDS-PAGE and analyzed by Western blot using anti-GFP antibody. Lanes 1, Adv-
BTN-EYFP milk; 2, Adv-BTN-EYFP supernatant tissue fraction; 3, Adv-BTN-EYFP 
tissue pellet; 4, Adv-XDH-EYFP milk; 5, Adv-XDH-EYFP tissue pellet; 6, Adv-





















igure 20. Distribution of Btn-EYFP in mouse mammary gland transduced with 
dv-BTN-EYFP. 
was transduced with Adv-BTN-EYFP on day 17 of pregnancy and 








A C57/BL6 mouse 
sa
microscopy. Btn-EYFP is distributed in the apical plasma membrane of epithelial 
cells (arrows) (a), (b): tissue sections from gland; (c): uninfused control; (d,e): Adv-













Figure 21. Distribution of Xdh-EYFP in mouse mammary gland transduced with 
Adv-XDH-EYFP 
 
A C57/BL6 mouse was transduced with Adv-XDH-EYFP on day 18 of pregnancy 
and sacrificed on day 3 of lactation. Fixed/ frozen tissue was examined by 
fluorescence microscopy. Xdh-EYFP is distributed in the cytoplasm and presumptive 
lipid droplets in the cytoplasm and milk (arrows) (a), (b): tissue sections of infused 
gland; (c): uninfused control. 
200µm 





crescents and caps containing the fluorescent proteins were evident (Figure 22, 23). 
These results suggest that the membrane undergoes morphology changes after 
secretion. These results were confirmed by 3-D analysis of labeled lipid droplets by 






Figure 22. Distribution of Btn-EYFP in secreted milk-lipid droplets 
 
A C57/BL6 mouse was infused with Adv-BTN-EYFP on day 15 of pregnancy. Milk 
was collected on the 3rd day of lactation and was studied by conventional 
fluorescence microscopy. Btn-EYFP was distributed unevenly, in the form of 








Figure 23. Distribution of Xdh-EYFP in secreted milk-lipid droplets 
 
A C57/BL6 mouse was infused with Adv-XDH-EYFP on day 15 of pregnancy and 
milk was collected on the 3rd day of lactation. Xdh-EYFP was distributed unevenly, 
in the form of crescents, caps, and discontinuities, around many of the droplets. (a), 









Figure 24. Z-stack confocal micrographs of Xdh-EYFP labeled lipid droplet 
 
A C57/BL6 mouse was infused with Adv-XDH-EYFP on day 18 of pregnancy into 
the left 4th gland, and milk was collected on the 3rd day of lactation. Z-stack of 1 µm 
confocal sections were taken. Note distribution of Xdh-EYFP is discontinuous on  







Figure 25. 3-Dimensional reconstruction of Xdh-EYFP labeled lipid droplet 
 
Mouse infusion and milk collection were as described in the legend to Figure 24. The 




igure 26. Z-stack confocal micrographs of Btn-EYFP labeled lipid droplet 








right 4  gland, and milk was collected on the 3  day of lactation. Z-stack of 1 µm 
confocal sections were taken. Note distribution of Btn-EYFP is discontinuou






Figure 27. 3-Dimensional reconstruction of Btn-EYFP labeled lipid droplet 
 
ouse infusion and milk collection were as described in the legend to  







Adenoviral-vector transduction has proven to be a suitable method for the 
efficient transduction of primary mammary cells, and in vivo transduction of mouse 
mammary glands has been evaluated for its efficacy and the potential problems of 
inflammation caused by the infused viruses and expressed proteins (53). This research 
has shown that infusion of adenoviral vectors in late pregnancy in the mouse leads to 
the successful transduction of the epithelial cells, which persists through the 5th day of 
lactation without causing localized inflammation (53).  
Based on our experiments, we show that infusion of adenoviral vectors in late 
regnancy is successful, and fusion protein expression is retained throughout 
r 
problems with tissue inflammation. The reason for this difference is not clear. 
Potential disadvantages of the adenoviral vector-infusion approach include problems 
in regulating the amount of protein expressed and potential instability of the 
expressed fusion proteins. However, we showed that both fusion proteins are stable in 
the transduced gland tissue (Figure 19). The potential overexpression of fusion 
proteins in the mammary gland needs to be addressed in future studies. 
In this research, we determined the optimal time and persistence of protein 
expression by fluorescence microscopy. A total of 23 mice were transduced with 
either Adv-BTN-EYFPs or Adv-XDH-EYFPs (Table 1) and the optimal time of 
fusion protein expression was determined by fluorescence microscopy of freshly 
collected milk at different stages of lactation (Figure 15, 16). Day 3 of lactation is the 
p
lactation. Unlike the previous study of Russell et al (53), we did not encounte
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earliest time we could collect milk and a large amount of milk could be collected 
round day 10, sufficient milk was available for study until weaning. Three mice 
were in





fused, milked, sacrificed, and studied under the same conditions. Consistent 
results suggested that fusion proteins were optimally expressed during the early 
period of lactation, namely the 3rd to 6th day. This is consistent with the extent of 
mouse mammary gland development after lactation. Weak expression of fusion 
proteins persisted until the 20th day of lactation, at which time the litters were weaned 
and the animals were sacrificed. Two attempts to transduce the mouse mammary 
gland in early lactation (day 1 and 2 of lactation, data n
ly because of interference from accumulated milk products. 
Determination of the optimum time for fusion protein expression was 
important because it provides evidence that successful in vivo transduction is 
consistent with the development and physiological status of the mammary gland due 
to pregnancy and lactation. In addition, it enables us to study the distribution of fusion 
proteins under optimal circumstances. 
Investigations of Btn1a1 and Xdh/Xo suggest that these two proteins function 
in milk-lipid secretion. Btn1a1 and Xdh/Xo are the two most abundant proteins in 
bovine MLGM (8) and both proteins are increased in expression and a
cy and lactation (32, 41, 47, 61). Moreover, Btn1a1 knock-out mice and 
Xdh/Xo heterozygous mice display abnormalities and disorganization in milk-lipid 
secretion (33, 50).  
Several studies based on molecular cloning techniques, topological assays, 
membrane fraction composition assays, and conventional immunomicroscopy have 
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been employed to determine the distribution of Btn1a1 and Xdh/Xo in lactating 
mammary tissue (29, 32, 42, 49). Investigators have suggested that Btn1a1 is 
concentrated at the apical membrane of secretory epithelial cells (9, 32, 61). 
However, questions about the results remain, partly because of several technical 
difficulties encountered when processing mammary tissue for microscopy. Most 
critically, for conventional immunomicroscopy, a balance has to be maintained 
between keeping the tissue in optimal morphology during preparation and fixation 
and in retaining the capability of antibodies to bind to epitopes within the tissue 
sections. This is especially difficult for lipid-rich tissues such as lactating mammary 
gland. By the approach of expressing adenoviral vectors encoding fusion proteins of 
Btn1a1
denoviral vectors encoding either protein 
fused to
lar lipid droplets (Wooding and Mather, unpublished data). The in 
vivo res
 and Xdh/Xo with variants of GFP, we can eliminate fixation artifacts and 
directly examine frozen tissue sections, which are preserved without chemical 
damage.  
To study the distribution of Btn1a1 and Xdh/Xo, we successfully transduced 
lactating mouse mammary tissue with a
 GFP variants. The approach of adenoviral vector-infusion into mouse 
mammary gland (53) provides new opportunities for examining the distribution of 
Btn1a1 and Xdh/Xo by fluorescence microscopy. A recent immune study employing 
Epon-embedded tissue sections and anti-peptide antibodies to Btn1a1 and Xdh/Xo 
showed clearly that Btn1a1 is localized to the apical membrane, and Xdh/Xo to the 
surface of intracellu
ults presented in this thesis are consistent with this study in that Btn1a1 is 
located at the apical plasma membrane (Figure 20), and Xdh/Xo is distributed in the 
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cytoplasm and surrounding lipid droplets (Figure 21). Both Btn1a1 and Xdh/Xo are 
localized in secreted milk-lipid droplets (Figure 15, 16). Fusion proteins of either 
Btn1a1 or Xdh/Xo were expressed as full-length proteins and in the expected 
locations. Furthermore, milk-lipid synthesis and secretion were regulated and normal, 
suggesting that the addition of EYFP did not affect the function of Btn1a1 and 
Xdh/Xo. 
Potential post-secretion changes in the structure of the MLGM have been 
debated for over 35 years (22, 28). Wooding originally proposed that the MLGM 
condenses the surface of the lipid droplet, vesiculates and blebbs off into skim milk 
(22). Thus the MLGM was postulated to consist of a continuous membrane 
immediately after the droplet’s separation from the secretory cell but to then undergo 
substantial structural rearrangements, including blebbing and the formation of 
crescents, and vesicles after secretion (22, 23, 24, 26). However, this mechanism was 








epted by many investigators because the tissue sections were fixed wit
glutaraldehyde and treated with post-fixation osmic acid and dehydrated.  
Freeze-etch study of membrane fusion during secretion (62) and of 
MLGM (28) has supported Wooding’s proposals and a schematic model w
introduced that provided a temporal description of post secretion membrane
rearrangements (28). However, direct visualization of these rearrangements in vi
was lacking until we were able to express fluorescently tagged fusion proteins 
lactating mammary gland directly. As shown by confocal microscopy, the protein and 
membrane coat of milk-lipid droplets is not evenly distributed around the l
droplet. Crescent-like-structures and blebbings in the middle of a continuous
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membrane were observed, confirming Wooding’s original interpretation of electron
micrographs. Thus as we propose now, the inner membrane of MLGM and the ou
surface of the milk-lipid droplet interact with each other and ultimately fuse, 
to thickened areas of protein coat under crescents and membrane vesicles. 






 are possible. FRAP and FLIP procedures can be initiated to determine the 
mobility of proteins in membranes before and after secretion and FRET can be used 
to investigate the binding and interaction between Btn1a1 and Xdh/Xo at the apical 
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